TW229213B - - Google Patents

Info

Publication number
TW229213B
TW229213B TW082102015A TW82102015A TW229213B TW 229213 B TW229213 B TW 229213B TW 082102015 A TW082102015 A TW 082102015A TW 82102015 A TW82102015 A TW 82102015A TW 229213 B TW229213 B TW 229213B
Authority
TW
Taiwan
Prior art keywords
glycosaminoglycans
alpha
new semi
synthetic glycosaminoglycans
good
Prior art date
Application number
TW082102015A
Other languages
English (en)
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Application granted granted Critical
Publication of TW229213B publication Critical patent/TW229213B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TW082102015A 1992-04-17 1993-03-19 TW229213B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO920140A IT1260136B (it) 1992-04-17 1992-04-17 Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3

Publications (1)

Publication Number Publication Date
TW229213B true TW229213B (zh) 1994-09-01

Family

ID=11338174

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082102015A TW229213B (zh) 1992-04-17 1993-03-19

Country Status (18)

Country Link
US (1) US5430132A (zh)
EP (1) EP0565862B1 (zh)
JP (1) JP2702377B2 (zh)
KR (1) KR0171623B1 (zh)
AT (1) ATE154615T1 (zh)
AU (1) AU658499B2 (zh)
CA (1) CA2093148C (zh)
DE (1) DE69311618T2 (zh)
DK (1) DK0565862T3 (zh)
ES (1) ES2103991T3 (zh)
FI (1) FI106555B (zh)
GR (1) GR3024582T3 (zh)
IL (1) IL105111A (zh)
IT (1) IT1260136B (zh)
NO (1) NO306305B1 (zh)
NZ (1) NZ247197A (zh)
TW (1) TW229213B (zh)
ZA (1) ZA931799B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1260137B (it) * 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
IT1264102B1 (it) * 1993-03-29 1996-09-10 Alfa Wassermann Spa Processo per la sintesi di glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonico sostituito con radicali
IT1264101B1 (it) * 1993-03-29 1996-09-10 Alfa Wassermann Spa Processo per la sintesi di glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2
US6127347A (en) * 1994-01-12 2000-10-03 Univ Michigan Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
US5583121A (en) * 1994-01-12 1996-12-10 Michigan State University Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
NO984143L (no) 1998-09-09 2000-03-10 Norsk Hydro As Ny prosess for å fremstille overflatemodifiserende stoffer
HUP0201712A3 (en) * 1999-06-30 2003-03-28 Weitz Jeffrey I Ancaster Clot associated coagulation factors inhibiting heparin compositions
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
AU2001291549A1 (en) * 2000-09-08 2002-03-22 Hamilton Civic Hospitals Research Development Inc. Antithrombotic compositions
JP4828795B2 (ja) * 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
CN102791742B (zh) * 2010-01-19 2014-12-24 动量制药公司 评价肝素制剂
CA3020369C (en) 2010-09-14 2019-11-26 University Of Miyazaki High purity heparin and production method therefor
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2017154938A1 (ja) * 2016-03-09 2017-09-14 株式会社糖鎖工学研究所 硫酸基および／またはリン酸基を有する糖の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987223A (en) * 1981-12-23 1991-01-22 Choay S.A. Derivatives of the uronic acid
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
US5200523A (en) * 1990-10-10 1993-04-06 Monsanto Company Synthesis of nojirimycin derivatives

Also Published As

Publication number Publication date
NO931181D0 (no) 1993-03-30
CA2093148C (en) 1999-01-26
FI931740A0 (fi) 1993-04-16
ITBO920140A1 (it) 1993-10-17
KR930021651A (ko) 1993-11-22
ATE154615T1 (de) 1997-07-15
NO306305B1 (no) 1999-10-18
ZA931799B (en) 1993-12-27
EP0565862B1 (en) 1997-06-18
AU3689693A (en) 1993-10-21
DE69311618D1 (de) 1997-07-24
EP0565862A3 (en) 1993-11-10
DE69311618T2 (de) 1997-12-11
GR3024582T3 (en) 1997-12-31
AU658499B2 (en) 1995-04-13
EP0565862A2 (en) 1993-10-20
ITBO920140A0 (it) 1992-04-17
NO931181L (no) 1993-10-18
IT1260136B (it) 1996-03-28
US5430132A (en) 1995-07-04
JPH0616704A (ja) 1994-01-25
DK0565862T3 (da) 1997-12-15
FI106555B (fi) 2001-02-28
JP2702377B2 (ja) 1998-01-21
NZ247197A (en) 1995-02-24
IL105111A (en) 1997-03-18
KR0171623B1 (ko) 1999-02-01
FI931740A (fi) 1993-10-18
CA2093148A1 (en) 1993-10-18
ES2103991T3 (es) 1997-10-01

Similar Documents

Publication Publication Date Title
TW239148B (zh)
TW229213B (zh)
DE3871637D1 (en) Pentasaccharide.
GR3024710T3 (en) Process for the synthesis of semisynthetic glycosaminoglycans containig alpha-L-galacturonic acid substituted with nucleophilic radicals in position 3.
GR3024416T3 (en) Process for the synthesis of semisynthetic glycosaminoglycans with heparin or heparan structure modified in position 2 of the alpha-L-iduronic-2-0-sulfate acid.